(Q34867700)

5 August 2017

1 reference

title

Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted? (English)

1 reference

5 August 2017

0 references

1 reference

2

Stewart Tepper

1 reference

5 August 2017

Richard G Wenzel

1

1 reference

5 August 2017

William E Korab

series ordinal

3

1 reference

5 August 2017

Fredrick Freitag

series ordinal

4

1 reference

5 August 2017

language of work or name

English

0 references

publication date

28 October 2008

1 reference

Annals of Pharmacotherapy

5 August 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

5 August 2017

volume

42

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1692-1696

1 reference

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)

5 August 2017

cites work

1 reference

Pharmacologic treatment of acute major depression and dysthymia. American College of Physicians-American Society of Internal Medicine

21 January 2018

1 reference

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

Migraine--current understanding and treatment

21 January 2018

1 reference

Sumatriptan contraindications and the serotonin syndrome.

21 January 2018

1 reference

21 January 2018

The Serotonin Syndrome

1 reference

21 January 2018

1 reference

Serotonin syndrome. A clinical update

21 January 2018

1 reference

Pathophysiology and management of the serotonin syndrome

21 January 2018

1 reference

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

21 January 2018

1 reference

A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action

21 January 2018

1 reference

Serotonin syndrome: early management with cyproheptadine

21 January 2018

1 reference

The serotonin syndrome, triptans, and the potential for drug-drug interactions

21 January 2018

1 reference

Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum

21 January 2018

1 reference

Serotonin syndrome complicating migraine pharmacotherapy

21 January 2018

1 reference

Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study

21 January 2018

1 reference

Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients

21 January 2018

1 reference

The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity

21 January 2018

1 reference

Serotonin syndrome associated with triptan monotherapy

21 January 2018

1 reference

21 January 2018

1 reference

Extracting value from case reports: lessons from serotonin toxicity.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1L260

1 reference

5 August 2017

1 reference